Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Naeije (Brussels, Belgium). Who to treat/who not to treat: L Heart disease. School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease

Member's Comments

No comment yet.

Related content which might interest you: Who to treat/who not to treat: L heart disease Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease Year: 2012 Heart disease in sarcoidosis/ our experience Source: Eur Respir J 2003; 22: Suppl. 45, 232s Year: 2003 Heart failure and COPD: an ignored combination? Source: Annual Congress 2008 - COPD – the holistic perspective Year: 2008 Heart disease co-morbidity in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 594s Year: 2005 Who to treat/who not to treat: Left heart disease Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2017 Who to treat/who not to treat: Left heart disease Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease Year: 2018 Breakout Sessions II: chronic lung and heart disease Source: ERS Summit on bridging the health divide in Europe 2012 Year: 2012 Relation of American Heart Association’s life’s simple 7 cardiovascular health factors with chronic obstructive pulmonary disease Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Treat-to-target strategies in pulmonary arterial hypertension: the importance of using multiple goals Source: Eur Respir Rev 2010 19: 272-278 Year: 2010 Mortality associated with the type of heart failure in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD Year: 2016 Cancer treatment in pulmonary hypertension: cause or cure? Source: Annual Congress 2013 –Ceremony for the ERS Award for Lifetime Achievement in Pulmonary Arterial Hypertension (financially supported by Actelion) followed by Symposium: Drug-induced pulmonary arterial hypertension Year: 2013 Pulmonary rehabilitation (PR) in adults with COPD and Heart Failure (HF); data from the UK 2015 National COPD:PR Audit Source: International Congress 2019 – Pulmonary rehabilitation for obstructive lung diseases Year: 2019 Heart - lung interaction Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 Heart rate variability during six-minute-walking test in chronic obstructive pulmonary disease Source: Annual Congress 2008 - COPD Year: 2008 Heart rhythm disorders in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 The effectiveness of anti-inflammatory therapy for chronic obstructive pulmonary disease complicated by ischemic heart disease (new medication - new opportunities) Source: International Congress 2014 – Comorbidities Year: 2014 The Study to Understand Mortality and Morbidity in COPD (SUMMIT) study protocol Source: Eur Respir J 2013; 41: 1017-1022 Year: 2013 Pulmonary hypertension associated with left heart disease Source: Eur Respir Mon 2012; 57: 119-137 Year: 2012